FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773838001: Antimigraine therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726730017 Antimigraine therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3726731018 Antimigraine therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antimigraine therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely sumatriptan (as sumatriptan succinate) 50 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing sumatriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing naproxen and sumatriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing naproxen and sumatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Sumatriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only naproxen and sumatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only sumatriptan in nasal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only sumatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only sumatriptan in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only naproxen and sumatriptan (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan succinate 12 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing methysergide in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methysergide (as methysergide maleate) 1 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing lisuride Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methysergide maleate 2 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing lisuride in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing methysergide Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only lisuride in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only methysergide in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Lisuride Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Methysergide Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lisuride maleate 200 microgram/1 each conventional release oral tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing dihydroergotamine in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing dihydroergotamine in nasal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing dihydroergotamine Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only dihydroergotamine in nasal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only dihydroergotamine in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Dihydroergotamine Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing dihydroergotamine in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing dihydroergotamine in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only dihydroergotamine in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only dihydroergotamine in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and ergotamine tartrate 2 milligram/1 each conventional release rectal suppository Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ergotamine tartrate 2 milligram/1 each conventional release sublingual tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing caffeine and ergotamine in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing caffeine and ergotamine in rectal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Ergotamine + Caffeine Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only caffeine and ergotamine in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only caffeine and ergotamine in rectal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only ergotamine in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Ergotamine Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing caffeine and ergotamine Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Rimegepant 75mg oral lyophilisates sugar free Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Eptinezumab 100mg/1ml solution for infusion vials Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Pizotifen 1mg/5ml oral suspension Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Rizatriptan 10mg oral lyophilisates sugar free Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Erenumab 140mg/1ml solution for injection pre-filled disposable devices Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5ml oral solution sugar free Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg orodispersible tablets Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5ml oral suspension Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Pizotifen 500micrograms/5ml oral suspension Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Erenumab 70mg/1ml solution for injection pre-filled disposable devices Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Sumatriptan 20mg/0.1ml nasal spray unit dose Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Sumatriptan 6mg/0.5ml solution for injection pre-filled syringes Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5ml oral solution Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Sumatriptan 10mg unit dose nasal spray Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Rizatriptan 5mg orodispersible tablets sugar free Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Pizotifen 750micrograms/5ml oral suspension Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Lisuride 200microgram tablets Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Zolmitriptan 5mg/0.1ml nasal spray unit dose Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Fremanezumab 225mg/1.5ml solution for injection pre-filled syringes Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Zolmitriptan 5mg orodispersible tablets Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Frovatriptan 2.5mg tablets Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Dihydroergotamine 1mg/1ml solution for injection ampoules Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Sumatriptan 3mg/0.5ml solution for injection pre-filled disposable devices Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Rizatriptan 10mg orodispersible tablets sugar free Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Sumatriptan 6mg/0.5ml solution for injection pre-filled disposable devices Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Sumatriptan 6mg/0.5ml solution for injection syringe refill Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier

Start Page 2 of 2

This concept is not in any reference sets

Back to Start